Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TET2 | Q6N021 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methacrylic Acid SCHEMBL19019806 | 0.88 | CYP4F2 (0.37) | TET2 | |
| Methacrylic Acid SCHEMBL19019794 | 0.86 | CYP4F2 (0.40) | — | |
| Methacrylic Acid SCHEMBL418672 | 0.85 | TET2 (0.33) | TET2 | |
| Methacrylic Acid SCHEMBL19019801 | 0.85 | CYP4F2 (0.39) | — | |
| Methacrylic Acid SCHEMBL28055936 | 0.83 | TET2 (0.34) | TET2 | |
| Methacrylic Acid SCHEMBL27716580 | 0.83 | TET2 (0.34) | TET2 | |
| Methacrylic Acid SCHEMBL165956 | 0.79 | TET2 (0.32) | TET2 | |
| SCHEMBL1674824 | 0.79 | — | — | |
| Methacrylic Acid SCHEMBL28348811 | 0.79 | TSHR (0.33) | — | |
| Methacrylic Acid SCHEMBL8637736 | 0.78 | TET2 (0.39) | TET2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110730673-B | High refractive index, high Abbe number intraocular lens materials | 爱尔康公司 | 2022-04-19 | — | — | CN | claimed |
| CN-110730673-A | High refractive index, high Abbe number intraocular lens materials | 爱尔康公司 | 2020-01-24 | — | — | CN | claimed |
| CN-113544120-B | Novel compound, composition containing same, self-repairing material, surface coating agent, paint, adhesive, battery material, and cured product | 株式会社ADEKA | 2023-05-02 | — | — | CN | disclosed |
| CN-113544120-A | Novel compound, composition containing same, and cured product | 株式会社ADEKA | 2021-10-22 | — | — | CN | disclosed |
| CN-107849203-B | (meth) acrylic block copolymer | 株式会社可乐丽 | 2020-04-24 | — | — | CN | disclosed |
| EP-3327053-B1 | (METH)ACRYLIC BLOCK COPOLYMER | KURARAY CO (JP) | 2020-03-25 | — | — | EP | disclosed |
| US-10426712-B2 | Dental polymerizable composition | KURARAY NORITAKE DENTAL INC. (JP) | 2019-10-01 | — | — | US | disclosed |
| US-20180208700-A1 | (METH)ACRYLIC BLOCK COPOLYMER | KURARAY CO., LTD. (JP) | 2018-07-26 | — | — | US | disclosed |
| EP-3327053-A1 | (METH)ACRYLIC BLOCK COPOLYMER | Kuraray Co., Ltd. (JP) | 2018-05-30 | — | — | EP | disclosed |
| US-20170290746-A1 | DENTAL POLYMERIZABLE COMPOSITION | KURARAY NORITAKE DENTAL INC. (JP) | 2017-10-12 | — | — | US | disclosed |
| US-20170240739-A1 | ACTIVE ENERGY RAY CURABLE COMPOSITIONS | KURARAY CO., LTD. (JP) | 2017-08-24 | — | — | US | disclosed |
| EP-3195846-A1 | DENTAL POLYMERIZABLE COMPOSITION | Kuraray Noritake Dental Inc. (JP) | 2017-07-26 | — | — | EP | disclosed |
| EP-3184563-A1 | ACTIVE ENERGY RAY-CURABLE COMPOSITION | Kuraray Co., Ltd. (JP) | 2017-06-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10426712-B2 | Dental polymerizable composition | MMAB, GRIN2B, CAD | TET2 250/4885 |
| US-20170290746-A1 | DENTAL POLYMERIZABLE COMPOSITION | MMAB, GRIN2B, CAD | TET2 250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.